Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

Biotechnology

Tarrytown, New York, United States
10,000+ employees
Founded 1988

Regeneron is a biotechnology company that invents, develops and commercializes medicines for people with serious diseases, including eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases. Its proprietary technology platforms, such as VelociSuite® and the Regeneron Genetics Center®, drive its in-house drug discovery and development.

  • 16 approved medicines developed in-house
  • Nearly 50 product candidates in clinical development across multiple therapeutic areas
  • VelociSuite® technology platforms (fully human and bispecific antibodies)
  • Regeneron Genetics Center® (3M+ exomes sequenced to date)

Recently from Regeneron Pharmaceuticals

Straight from the company's own channels.

Latest videos

3.2K subscribers · 145 videos

Visit channel
Ireland's Young Scientists at Regeneron ISEF 2026: from the classroom to the world stage67 views · 5 days ago

Open roles at Regeneron Pharmaceuticals

529 matching roles

Showing 12 of 529 roles